User profiles for Raja Dhar
Dr. Raja DharDirector and Head, Department of Pulmonology, CK Birla Hospitals, Kolkata. Verified email at icsorg.net Cited by 1875 |
[HTML][HTML] Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of …
Background Bronchiectasis is a common but neglected chronic lung disease. Most
epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income …
epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income …
Interstitial lung disease in India. Results of a prospective registry
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic
inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little …
inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little …
Bronchiectasis
Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms of …
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms of …
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
Background Antibiotic resistance is a major global health problem and pathogens such as
meticillin-resistant Staphylococcus aureus (MRSA) have become of particular concern in the …
meticillin-resistant Staphylococcus aureus (MRSA) have become of particular concern in the …
[HTML][HTML] Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practice
…, S Chaudhari, R Chokhani, D Christopher, R Dhar… - Lung India, 2019 - journals.lww.com
Globally, pneumococcal diseases are a significant public health concern. They are preventable
and frequently occur among older adults. Major risk factors for the disease are extremes …
and frequently occur among older adults. Major risk factors for the disease are extremes …
Global impact of bronchiectasis and cystic fibrosis
M Redondo, H Keyt, R Dhar, JD Chalmers - Breathe, 2016 - Eur Respiratory Soc
Educational aims To recognise the clinical and radiological presentation of the spectrum of
diseases associated with bronchiectasis. To understand variation in the aetiology, …
diseases associated with bronchiectasis. To understand variation in the aetiology, …
Progressive pulmonary fibrosis: an expert group consensus statement
This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …
[HTML][HTML] Guidelines for diagnostic flexible bronchoscopy in adults: Joint Indian Chest Society/National College of chest physicians (I)/Indian association for …
…, MK Daga, RK Das, G D'Souza, R Dhar… - Lung India, 2019 - journals.lww.com
Flexible bronchoscopy (FB) is commonly performed by respiratory physicians for diagnostic
as well as therapeutic purposes. However, bronchoscopy practices vary widely across India …
as well as therapeutic purposes. However, bronchoscopy practices vary widely across India …
Allergic bronchopulmonary aspergillosis in India
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated
reactions mounted against Aspergillus fumigatus. The disorder most commonly …
reactions mounted against Aspergillus fumigatus. The disorder most commonly …
Asthma Insights and Management in India: Lessons Learnt from the Asia Pacific-Asthma Insights and Management (AP-AIM) Study.
Background Despite a better understanding of the pathophysiology of asthma, presence of
reliable diagnostic tools, availability of a wide array of effective and affordable inhaled drugs …
reliable diagnostic tools, availability of a wide array of effective and affordable inhaled drugs …